← FDA DRUG APPROVALS
FDA ANDA · ANDA216558
OSHIH
norethindrone acetate and ethinyl estradiol and ferrous fumarate
Sponsor: AUROBINDO PHARMA
APPLICATION
ANDA216558
TYPE
ANDA
ORIGINAL APPROVAL
2023-12-06
LATEST ACTION
2023-12-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
OSHIHDiscontinued
ETHINYL ESTRADIOL 0.02MG, NORETHINDRONE ACETATE 1MG · TABLET · ORAL
Approval history
2023-12-06UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.